Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-EN Version v6-EN
Language English English
Date Updated 2021-09-18 2021-09-17
Drug Identification Number 02253437 02253437
Brand name ALIMTA ALIMTA
Common or Proper name PEMETREXED DISODIUM FOR INJECTION PEMETREXED DISODIUM FOR INJECTION
Company Name ELI LILLY CANADA INC ELI LILLY CANADA INC
Ingredients PEMETREXED PEMETREXED
Strength(s) 500MG 500MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 500mg /50mL vial 500mg /50mL vial
ATC code L01BA L01BA
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2021-09-17 2021-09-17
Actual discontinuation date 2021-09-17 2021-09-17
Remaining supply date 2021-09-17 2021-09-17
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments Please contact Eli Lilly Canada's Response Centre 1-888-545-5972 should you have any questions. Please contact Eli Lilly Canada's Response Centre 1-888-545-5972 should you have any questions.
Health Canada comments